OPTH Latest Press Releases

-- October 26, 2026 --

Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity Globe Newswire 8:00 AM

-- October 20, 2026 --

Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia Globe Newswire 8:30 AM

-- October 7, 2026 --

Optimi Health to Present at the ThinkEquity Conference Globe Newswire 9:00 AM

-- September 29, 2026 --

Optimi Health Appoints Melanie Pump to Board of Directors Globe Newswire 7:30 AM

-- September 23, 2026 --

Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply Globe Newswire 9:00 AM

-- September 22, 2026 --

Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer Globe Newswire 9:00 AM

-- September 16, 2026 --

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder Globe Newswire 8:25 AM

-- September 10, 2026 --

Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder Globe Newswire 8:45 AM

-- September 8, 2026 --

Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:30 AM

-- August 14, 2026 --

Optimi Health Establishes Discretionary Equity Facility Globe Newswire 4:55 PM

-- June 29, 2026 --

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression PRNewswire 11:15 AM

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression Globe Newswire 9:00 AM

-- June 16, 2026 --

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research PRNewswire 12:38 PM

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research Globe Newswire 8:30 AM

-- June 10, 2026 --

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial PRNewswire 2:25 PM

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial Globe Newswire 9:15 AM

-- June 8, 2026 --

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development PRNewswire 12:55 PM

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes